NCI Bertagnolli to announce National Cancer Plan that would “align broad societal engagement” to reduce cancer mortality March 24, 2023Vol.49 No.12By Matthew Bin Han Ong
Trials & Tribulations Does salpingectomy prevent ovarian cancer? Let’s prove it.The SOROCk clinical trial, NRG CC008 (NCT04251052) March 17, 2023Vol.49 No.11By Kathryn P. Pennington, Warner K. Huh, Sandra Russo and Joan L. Walker
White House Biden requests $503M increase for NCI, new funds for the Moonshot, $1B for ARPA-H in FY24 March 10, 2023Vol.49 No.10By Matthew Bin Han Ong
Funding Opportunities Cancer Grand Challenges announces global research funding opportunity with nine new challenges March 10, 2023Vol.49 No.10
Clinical Roundup NCI Center for Cancer Research study identifies ecDNA as driver of SCLC March 10, 2023Vol.49 No.10
Grant-funded, investigator-initiated trials fail to bounce back from COVID as 50% of research staff left for higher-paying jobs February 17, 2023Vol.49 No.07By Matthew Bin Han Ong
Drugs & Targets Gritstone bio and NCI collaborate to evaluate neoantigen cell therapy + vaccine for mutant KRAS solid tumors February 17, 2023Vol.49 No.07
NCI Bertagnolli raises paylines, creates Clinical Trials Innovation Unit, and announces National Cancer Plan February 10, 2023Vol.49 No.06By Matthew Bin Han Ong
White House Biden places cancer in top spot on Unity Agenda; announces new Moonshot programs February 10, 2023Vol.49 No.06By Matthew Bin Han Ong
Conversation with The Cancer Letter Jedd Wolchok: Weill Cornell’s path to NCI designation runs through Brooklyn and Queens January 13, 2023Vol.49 No.02By Paul Goldberg
